Image of hexagons and lines

DC Discussion Group

Home / Event

September 14, 2022

Washington, D.C., United States
Virtual

Contact: Alissa Doyle
Phone: 510-428-0740

Role of Risk Assessment in Advanced Technologies | September 14, 2022 11:00 - 12:30 EDT

Talks in this DC Discussion Group will describe some of these experiences and efforts by industry and regulators to better ensure the quality of biological products. Jean-Pol Cassart, from GlaxoSmithKline Belgium and Kevin Carrick from US Pharmacopeia, USA will discuss the role of risk assessment in advanced technologies; a panel discussion with live attendee interaction will follow. This virtual discussion group is free to attend, but you must register in advance. Registration will close September 13, 2022.

Featured Speakers:

Jean-Pol Cassart from GlaxoSmithKline Pharmaceuticals s.a/n.v, Belgium’s Viral Safety Program will address the investigation into PCV-1 contamination of GSK’s rotavirus vaccine and the development of their viral risk assessment and response plan.

Kevin Carrick from US Pharmacopeia, USA will discuss the 2008 heparin contamination.

For more information, visit  Discussion Groups